Home > Insider Trading > Filing (0001140361-15-001481)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1228627	Rexahn Pharmaceuticals Inc.	RNN	Pharmaceutical Preparations (2834)	113516358

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1316420	Ho Chang Ahn	C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-08	80,000	$0.80	6,090,000	No	4	M	Direct
Common Stock	Disposition	2015-01-08	80,000	$0.90	6,010,000	No	4	S	Direct
Common Stock	Acquisiton	2015-01-09	186,212	$0.80	6,196,212	No	4	M	Direct
Common Stock	Disposition	2015-01-09	186,212	$0.92	6,010,000	No	4	S	Direct
Common Stock	Acquisiton	2015-01-12	48,444	$0.80	6,058,444	No	4	M	Direct
Common Stock	Disposition	2015-01-12	48,444	$0.91	6,010,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to purchase)	Disposition	2015-01-08	80,000	$0.00	80,000	$0.80
Common Stock	Stock Option (right to purchase)	Disposition	2015-01-09	186,212	$0.00	186,212	$0.80
Common Stock	Stock Option (right to purchase)	Disposition	2015-01-12	48,444	$0.00	48,444	$0.80

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
783,807	2015-01-20	No	4	M	Direct
597,595	2015-01-20	No	4	M	Direct
549,151	2015-01-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	500,000	Indirect	By spouse

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9098 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price of $0.9155 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price of $0.9137 per share represents a weighted average of sales prices from $0.90 to $0.9351 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Options vested and became exercisable based on the following schedule: 300,000 on January 20, 2006, 300,000 on January 20, 2007, and 400,000 on January 20, 2008.